NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
106-120 of 394

Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
NeuroFrontiersModern MS Care: Navigating Treatment Options for Better Patient Outcomes

Reevaluating Natalizumab Dosing in RRMS: Insights from the NOVA Trial
NeuroFrontiersReevaluating Natalizumab Dosing in RRMS: Insights from the NOVA Trial

Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the MAPLE-MS Pharmacovigilance Program
NeuroFrontiersPregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the MAPLE-MS Pharmacovigilance Program

Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
NeuroFrontiersRecognizing MS: Understanding Symptoms and Avoiding Misdiagnosis

MS Relapse vs Pseudo-Relapse After Infection: COVID-19 Shows Divergent Risk Pattern
NeuroFrontiersMS Relapse vs Pseudo-Relapse After Infection: COVID-19 Shows Divergent Risk Pattern

Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
NeuroFrontiersEpigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
- advertisement

Understanding MS: Managing Hidden and Overlooked Symptoms
NeuroFrontiersUnderstanding MS: Managing Hidden and Overlooked Symptoms

Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
NeuroFrontiersAdvancing MS Care: Evolving Treatments and High-Efficacy Approaches

Recognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care
NeuroFrontiersRecognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care

Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
NeuroFrontiersSafety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts

ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
NeuroFrontiersASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context

New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
NeuroFrontiersNew-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
- advertisement

Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
NeuroFrontiersMetabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial

Examining Care Collaborations for Patients with SMA
NeuroFrontiersExamining Care Collaborations for Patients with SMA

Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
NeuroFrontiersEarly Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
























